Status:
UNKNOWN
Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis
Lead Sponsor:
Sohag University
Conditions:
Localized Psoriasis
Eligibility:
All Genders
15-65 years
Phase:
NA
Brief Summary
The aim of the present study is to evaluate the efficacy of intralesional injection of methotrexate in comparison with Intralesional Injection of Triamcinolone Acetonid in localized psoriasis (body su...
Detailed Description
study enrolling 30 patients of localized psoriasis. 15 patients received intralesional methotrexate : * Taking aseptic condition ,One psoriatic plaque will treated with Intralesional injection of met...
Eligibility Criteria
Inclusion
- patients with localized Psoriasis (body surface area\<10%)
Exclusion
- Patient refusal. Generalized psoriasis. Pregnancy. Lactation. Immunocompromised patients . Patients with history of hypersensitivity to methotrexate. Patients with other inflammatory skin disorders. Patients with chronic hepatic, renal , pulmonary ,or haematological disorders. patients on treatment for psoriasis .
Key Trial Info
Start Date :
May 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 21 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05408208
Start Date
May 21 2022
End Date
May 21 2023
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt